Luis Bermudez-Humaran
5Patents
1h-index
21Co-inventors
43Inventor score
Filing activity: Sep 18, 2014 → Jun 19, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10238697B2 | Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeutics | Human Necessities | 2 | Active |
| US10328132B2 | Compositions for the inhibition of Giardia lamblia | Emerging Cross-Sectional Technologies | 1 | Active |
| US9688742B2 | Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) | Chemistry; Metallurgy | 1 | Active |
| US11103564B2 | Compositions for the inhibition of Giardia lamblia | Emerging Cross-Sectional Technologies | 0 | Active |
| US11013783B2 | Anti-inflammatory peptides and methods for treating inflammatory diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.